Managing Iron Deficiency in Heart Failure: Recognizing the Need for Treatment and Effective Management Strategies

This activity is sponsored by Postgraduate Healthcare Education, LLC (PHE) and supported by an independent medical education grant from American Regent, Inc.

Registration & Dates for Activities

Wednesday, December 18, 2024
2:00-3:30 PM ET

Faculty

Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Cardiovascular Clinical Pharmacist, Associate Adjunct Professor
Department of Pharmacy Practice and Science
University of Kentucky College of Pharmacy
Lexington, Kentucky

Kathleen A. Lusk, PharmD, BCPS, BCCP
Professor and Vice Chair, Department of Pharmacy Practice
University of the Incarnate Word Feik School of Pharmacy
Adjunct Assistant Professor, Division of Cardiology, Department of Medicine
UT Health San Antonio
San Antonio, Texas

FINANCIAL DISCLOSURES

Craig J. Beavers and Kathleen A. Lusk have no relevant affiliations, no financial relationships or relationships to products or devices with a commercial interest related to the content of this activity to disclose.

The clinical reviewer, Darrell Hulisz, RPh, PharmD has no relevant affiliations, no financial relationships or relationships to products or devices with a commercial interest related to the content of this activity to disclose.

Susanne Kwas, MSHF, BSN, RN, Robin Carrino and Alexia Hynes, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

ACCREDITATION STATEMENTS

PHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-24-095-L01-P
Credits: 1.5 hours (0.15 ceu)
Estimated time to complete activity: 90 minutes

Location: From the convenience of your home or business; accessible via both PC and MAC
Fee Information: There is no fee. This is a free continuing education activity.
Type of Activity: Application
Media: Internet

TARGET AUDIENCE

This activity is designed to meet the educational needs of managed care, specialty, and hospital/health-system pharmacists nationwide.

HOW TO EARN CREDIT

Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live webinar; and 3) complete the evaluation form directly after the event within a maximum of within 60 days of attending the live session. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

Goal

The goal of this educational activity is to provide managed care, specialty, and hospital/health-system pharmacists with the knowledge and skills necessary to participate in the management of ID and ID anemia in patients with heart failure.

LEARNING OBJECTIVES

After participating in this activity, learners will demonstrate the ability to:

• Explain the association between iron deficiency (ID) and heart failure (HF), including onset, clinical presentation, and criteria for diagnosis
• Identify challenges that hinder the diagnosis and initiation of appropriate treatment of ID in HF
• Discuss guideline recommendations for the use of intravenous (IV) iron therapy for patients with HF
• Analyze key research studies supporting the selection and dosing of IV iron therapy in patients with HF
• Formulate approaches for individualizing management of ID in HF, including dosage and administration strategies for IV iron therapy

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac & Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher, & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Peripherals: Computer speakers or headphones
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Disclosure of Unlabeled Use and Disclaimer:

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC or American Regent, Inc. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities. The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this activity have not been evaluated by the FDA.